Short‐term all‐cause mortality · people with low‐risk acute pulmonary embolism
2 findings from 1 review
Long‐term all‐cause mortality · people with low‐risk acute pulmonary embolism
Outpatient showed no clear difference in long‐term all‐cause mortality compared with inpatient treatment (low certainty).
1 finding from 1 review
Major bleeding · people with low‐risk acute pulmonary embolism
Outpatient showed no clear difference in major bleeding compared with inpatient treatment (low certainty).
2 findings from 1 review
Minor bleeding · people with low‐risk acute pulmonary embolism
Outpatient showed no clear difference in minor bleeding compared with inpatient treatment (low certainty).
1 finding from 1 review
Recurrent PE · people with low‐risk acute pulmonary embolism
Outpatient may leads to higher recurrent PE compared with inpatient treatment (low certainty).
1 finding from 1 review
Treatment failure · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in treatment failure compared with inpatients ‐ adults (moderate certainty).
1 finding from 1 review
Adverse drug reactions · Children with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in adverse drug reactions compared with inpatients ‐ children (low certainty).
1 finding from 1 review
Duration of neutropaenia (days) · Children with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Length of hospitalisation (days) · Children with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Duration of antimicrobial treatment (days) · Children with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
All‐cause mortality · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in mortality compared with inpatients ‐ adults (moderate certainty).
1 finding from 1 review
Fever clearance time · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Adverse drug reactions · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in adverse drugs reactions compared with inpatients ‐ adults (low certainty).
1 finding from 1 review
Duration of neutropaenia (days) · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Length of hospitalisation (days) · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Treatment failure · Children with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in treatment failure compared with inpatients ‐ children (moderate certainty).
1 finding from 1 review
All‐cause mortality · Children with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in mortality compared with inpatients ‐ children (moderate certainty).
1 finding from 1 review
Fever clearance time · Children with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Quantity of service provision ‐ number of outpatients visits, specialist visits, or hospitalisations · healthcare providers working in outpatient healthcare settings
1 finding from 1 review
Patient readmissions · people with severe mental disorders
COURT ORDERED OUTPATIENT COMMITMENT showed no clear difference in health service outcomes: 1. Readmission to hospital by 11 to 12 months compared with ENTIRELY VOLUNTARY CARE (low certainty).
1 finding from 1 review